SAN DIEGO, Nov. 11, 2024 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on November 10, 2024, the Compensation Committee of Crinetics’ Board of Directors granted non-qualified stock option awards to purchase an aggregate of 99,500 shares of its common stock to eleven new non-executive employees under the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan (the “2021 Inducement Plan”). The stock options were granted as inducements material to the employees entering into employment with Crinetics in accordance with Nasdaq Listing Rule 5635(c)(4).
The latest data release from the Commodity Futures Trading Commission (CFTC) reveals a marginal improvement…
Traders and economists are taking a keen interest in the latest update from the Commodity…
In an updated report dated April 18, 2025, the Commodity Futures Trading Commission (CFTC) has…
The Commodity Futures Trading Commission (CFTC) has reported an improvement in wheat speculative net positions…
In its latest release, the U.S. Commodity Futures Trading Commission (CFTC) reported a decrease in…
Amid market turmoil, will Bitcoin keep going up or is it due for another correction?…
This website uses cookies.